- Home
- NRIM vs ESPR Comparison
NRIM vs ESPR Comparison
Compare NRIM & ESPR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- NRIM
- ESPR
- Stock Information
- Founded
- NRIM 1990
- ESPR 2008
- Country
- NRIM United States
- ESPR United States
- Employees
- NRIM N/A
- ESPR N/A
- Industry
- NRIM Savings Institutions
- ESPR Biotechnology: Pharmaceutical Preparations
- Sector
- NRIM Finance
- ESPR Health Care
- Exchange
- NRIM Nasdaq
- ESPR Nasdaq
- Market Cap
- NRIM 369.8M
- ESPR 319.2M
- IPO Year
- NRIM N/A
- ESPR 2013
- Fundamental
- Price
- NRIM $82.85
- ESPR $2.12
- Analyst Decision
- NRIM
- ESPR Buy
- Analyst Count
- NRIM 0
- ESPR 4
- Target Price
- NRIM N/A
- ESPR $8.17
- AVG Volume (30 Days)
- NRIM 22.7K
- ESPR 4.8M
- Earning Date
- NRIM 10-23-2024
- ESPR 11-07-2024
- Dividend Yield
- NRIM 2.99%
- ESPR N/A
- EPS Growth
- NRIM 22.45
- ESPR N/A
- EPS
- NRIM 5.86
- ESPR N/A
- Revenue
- NRIM $141,590,000.00
- ESPR $295,451,000.00
- Revenue This Year
- NRIM N/A
- ESPR $198.22
- Revenue Next Year
- NRIM $3.03
- ESPR $25.83
- P/E Ratio
- NRIM $14.14
- ESPR N/A
- Revenue Growth
- NRIM 12.70
- ESPR 187.12
- 52 Week Low
- NRIM $43.92
- ESPR $1.08
- 52 Week High
- NRIM $85.06
- ESPR $3.40
- Technical
- Relative Strength Index (RSI)
- NRIM 68.47
- ESPR 50.12
- Support Level
- NRIM $73.11
- ESPR $1.87
- Resistance Level
- NRIM $78.00
- ESPR $2.60
- Average True Range (ATR)
- NRIM 2.76
- ESPR 0.17
- MACD
- NRIM 1.70
- ESPR -0.01
- Stochastic Oscillator
- NRIM 89.66
- ESPR 34.25
About NRIM Northrim BanCorp Inc
Northrim BanCorp Inc is a bank holding company. The company operates in two segments: Community Banking and Home Mortgage Lending. It generates maximum revenue from the Community Banking segment. It offers to spend and save products such as checking, savings, money market accounts, debit cards, cashback rewards, and credit cards. It also includes loans and credit lines, mortgage loans, investment, and plan products.
About ESPR Esperion Therapeutics Inc.
Esperion Therapeutics Inc is a pharmaceutical company. It specializes in developing and commercializing accessible, oral, once-daily, non-statin medicines for patients struggling with elevated low-density lipoprotein cholesterol. The firm has the business of researching, developing and commercializing therapies for the treatment of patients with the elevated low-density lipoprotein cholesterol operating segment. Its products include NEXLETOL, NEXLIZET, NILEMDO and NUSTENDI. The Company manages its business in one operating segment, which is the business of researching, developing and commercializing therapies for the treatment of patients with elevated LDL-C.